Pharmaceutical Research and Manufacturers of America (PhRMA)
Registered Principal Details
Business Or Interest:
Research and manufacturing pharmaceuticals organizations
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries
CEO Name:
Stephen Ubl
Vice President, State Advocacy
Research and manufacturing pharmaceuticals organizations
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries
CEO Name:
Stephen Ubl
Vice President, State Advocacy
Contact
KM
Kenneth McKay
950 F Street NW, Suite 300
Washington, DC 20004
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org
950 F Street NW, Suite 300
Washington, DC 20004
(202) 835-3547
kmckay@phrma.org
http://www.phrma.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Saiza Elayda | Exclusive Duties No | Authorized On 12/13/2018 | Withdrawn On 1/20/2020 |
| Thomas E Moore | Exclusive Duties No | Authorized On 12/17/2018 | Withdrawn On N/A |
| Peter Fjelstad | Exclusive Duties No | Authorized On 5/11/2020 | Withdrawn On N/A |
Lobbying Interests
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
oppose prescription drug importation program
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
oppose prescription drug importation program
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
oppose provisions related to pharmaceutical price reporting and disclosure
3/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
oppose provisions related to pharmaceutical price reporting and disclosure
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
COVID-19 Executive and other orders
COVID-19 Executive and other orders
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/23/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/23/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Governor's Rx Task Force
Governor's Rx Task Force
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/23/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 January - June $34,277.63 |
2019 July - December $32,532.41 |
2020 January - June $38,275.00 |
2020 July - December $37,829.49 |
Total $142,914.53 |
| Total Hours Communicating | 2019 January - June 21.50 |
2019 July - December 8.00 |
2020 January - June 4.00 |
2020 July - December 9.00 |
Total 42.50 |
| Total Hours Other | 2019 January - June 15.50 |
2019 July - December 27.00 |
2020 January - June 27.50 |
2020 July - December 37.50 |
Total 107.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 25% |
2019 July - December 15% |
2020 January - June |
2020 July - December |
Total 9% |
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 25% |
2019 July - December 10% |
2020 January - June |
2020 July - December |
Total 9% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June |
2019 July - December |
2020 January - June 25% |
2020 July - December |
Total 5% |
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June |
2019 July - December |
2020 January - June 55% |
2020 July - December 65% |
Total 32% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication